rewirebio.iobenchmarks
Configuration

All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)

All panel fragmentomic metrics combined, GLMnet multinomial classifier: All Combined features from panel reads (20-500 bp inserts); elastic-net multinomial logistic regression (GLMnet), hyperparameters by Latin hypercube search with 5-fold inner cross-validation, up-sampling of minority classes.

8 evaluations · 60 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025). Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluations and results

8 evaluations · 60 results. Different protocols are not a single leaderboard.

Sorted by AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (Bladder vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (Bladder vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (Bladder vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (Bladder vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (ERneg vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (ERneg vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (ERneg vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (ERneg vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (ERpos vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (ERpos vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (ERpos vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (ERpos vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Guardant360 CDx genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Tempus xF genes)AUROC (mean over 9 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)AUROC (mean over 9 phenotypes of the median one-vs-rest AUROCs; Full panel genes)AUROC (mean over 9 phenotypes of the median one-vs-rest AUROCs; Guardant360 CDx genes)AUROC (mean over 9 phenotypes of the median one-vs-rest AUROCs; Tempus xF genes)AUROC (NEPC vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (NEPC vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (NEPC vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (NEPC vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (NSCLC vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (NSCLC vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (NSCLC vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (NSCLC vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (RCC vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (RCC vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (RCC vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (RCC vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)AUROC (SCLC vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (SCLC vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (SCLC vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)AUROC (SCLC vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC, Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)1 (best in column)Not reportedNot reportedNot reported0.983Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.954Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.896Not reportedNot reportedNot reported0.958Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC, University of Wisconsin targeted cfDNA cohort (431 samples)0.969Not reportedNot reportedNot reported0.984 (best in column)Not reportedNot reportedNot reported0.953Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.896Not reportedNot reportedNot reported0.959Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.931Not reportedNot reportedNot reported0.986Not reportedNot reportedNot reported0.85Not reportedNot reportedNot reported0.9Not reportedNot reportedNot reported0.878Not reportedNot reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC, Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)Not reported1 (best in column)Not reportedNot reportedNot reported0.983Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.945Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.894Not reportedNot reportedNot reported0.956Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC, Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)Not reportedNot reported0.999 (best in column)Not reportedNot reportedNot reported0.974 (best in column)Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.919Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.868Not reportedNot reportedNot reported0.94Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC, Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)Not reportedNot reportedNot reported1 (best in column)Not reportedNot reportedNot reported0.97Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.934Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.879Not reportedNot reportedNot reported0.946Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 UW cohort, full panel: multinomial phenotype AUROC, University of Wisconsin targeted cfDNA cohort (431 samples)Not reported0.967Not reportedNot reportedNot reported0.985 (best in column)Not reportedNot reportedNot reported0.947Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.867Not reportedNot reportedNot reported0.951Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.921Not reportedNot reportedNot reported0.971Not reportedNot reportedNot reported0.839Not reportedNot reportedNot reported0.887Not reportedNot reportedNot reported0.873Not reportedNot reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 UW cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC, University of Wisconsin targeted cfDNA cohort (431 samples)Not reportedNot reported0.974Not reportedNot reportedNot reported0.974 (best in column)Not reportedNot reportedNot reported0.914Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.907Not reportedNot reportedNot reported0.96Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.926Not reportedNot reportedNot reported0.985Not reportedNot reportedNot reported0.838Not reportedNot reportedNot reported0.919Not reportedNot reportedNot reported0.86Not reported
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)EvaluationHelzer et al. 2025 UW cohort, Tempus xF gene subset: multinomial phenotype AUROC, University of Wisconsin targeted cfDNA cohort (431 samples)Not reportedNot reportedNot reported0.97Not reportedNot reportedNot reported0.982 (best in column)Not reportedNot reportedNot reported0.941Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.896Not reportedNot reportedNot reported0.96Not reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reported0.933Not reportedNot reportedNot reported0.982Not reportedNot reportedNot reported0.873Not reportedNot reportedNot reported0.927Not reportedNot reportedNot reported0.865
All 60 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.954 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.896 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.958 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Prostate'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.945 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.894 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.956 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Prostate'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.919 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail guardant360 (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-guardant360

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Guardant360 CDx', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.868 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail guardant360 (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-guardant360

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Guardant360 CDx', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.94 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Guardant360 CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail guardant360 (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-guardant360

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Guardant360 CDx', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail guardant360 (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-guardant360

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Guardant360 CDx', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Guardant360 CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.974 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Guardant360 CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail guardant360 (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-guardant360

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Guardant360 CDx', row 'All Combined', column 'Prostate'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.934 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail tempus xf (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-tempus-xf

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Tempus xF', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.879 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail tempus xf (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-tempus-xf

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Tempus xF', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.946 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Tempus xF genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail tempus xf (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-tempus-xf

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Tempus xF', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Tempus xF genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail tempus xf (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-tempus-xf

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Tempus xF', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, Tempus xF gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.97 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Tempus xF genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail tempus xf (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-tempus-xf

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Tempus xF', row 'All Combined', column 'Prostate'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: University of Wisconsin targeted cfDNA cohort (431 samples)
0.953 AUROC (Bladder vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on uw foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-uw-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S2 (PDF caption), block 'Foundation One CDx' (printed label; the article names this subset FoundationOne Liquid CDx), row 'All Combined', column 'Bladder'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: University of Wisconsin targeted cfDNA cohort (431 samples)
0.896 AUROC (ERneg vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on uw foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-uw-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S2 (PDF caption), block 'Foundation One CDx' (printed label; the article names this subset FoundationOne Liquid CDx), row 'All Combined', column 'ERneg'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: University of Wisconsin targeted cfDNA cohort (431 samples)
0.959 AUROC (ERpos vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on uw foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-uw-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S2 (PDF caption), block 'Foundation One CDx' (printed label; the article names this subset FoundationOne Liquid CDx), row 'All Combined', column 'ERpos'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: University of Wisconsin targeted cfDNA cohort (431 samples)
0.931 AUROC (mean over 9 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on uw foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-uw-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S2 (PDF caption), block 'Foundation One CDx' (printed label; the article names this subset FoundationOne Liquid CDx), row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 UW cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: University of Wisconsin targeted cfDNA cohort (431 samples)
0.986 AUROC (NEPC vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on uw foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-uw-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S2 (PDF caption), block 'Foundation One CDx' (printed label; the article names this subset FoundationOne Liquid CDx), row 'All Combined', column 'NEPC'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-helzer2025-config-all-combined.

Source locator: Tables S1-S2 row label; Methods P23-P30

Related records

How to cite

All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025). Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ctdnalit-20261011-helzer2025-config-all-combined/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction